Israel Discount Bank of New York’s AstraZeneca AZN Stock Holding History

Israel Discount Bank of New York’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-38	Closed	-$3K	–	113
2019 Q1	$3K	Hold	38	–	–	﹤0.01%	412
2018 Q4	$3K	Sell	38 -22	-37%	-$1.72K	﹤0.01%	412
2018 Q3	$5K	Sell	60 -53	-47%	-$4.01K	﹤0.01%	393
2018 Q2	$8K	Hold	113	–	–	0.01%	384
2018 Q1	$8K	Hold	113	–	–	0.01%	392
2017 Q4	$8K	Hold	113	–	–	0.01%	395
2017 Q3	$8K	Buy	113 +25	+28%	+$1.58K	0.01%	396
2017 Q2	$6K	Hold	88	–	–	﹤0.01%	403
2017 Q1	$5K	Sell	88 -462	-84%	-$26.9K	﹤0.01%	413
2016 Q4	$30K	Buy	+550	New	+$31.2K	0.03%	352

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Israel Discount Bank of New York's AZN Position: Q2 2019 in Review

Israel Discount Bank of New York sold out of AstraZeneca (AZN) in Q2 2019, closing a stake of 38 shares — an estimated $3K sold.

Israel Discount Bank of New York first reported a position in AZN in Q4 2016 and held it in 10 quarters. The position peaked at $30K in Q4 2016. 546 funds tracked by Wall St. Rank hold AZN as of Q2 2019.

Israel Discount Bank of New York reported no remaining AstraZeneca position as of Q2 2019 after selling out during the quarter.
Israel Discount Bank of New York sold 38 AstraZeneca shares in Q2 2019, an estimated $3K.
Israel Discount Bank of New York first reported a position in AstraZeneca in Q4 2016 and held it in 10 quarters.
Israel Discount Bank of New York's AstraZeneca position peaked at $30K in Q4 2016.
546 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2019.

Based on Israel Discount Bank of New York's 13F filing for Q2 2019, filed 14 Aug 2019.